Last reviewed · How we verify

Ocimum Sanctum

Composite Interceptive Med Science · Phase 1 active Small molecule

Ocimum Sanctum (Holy Basil/Tulsi) is a traditional herbal extract marketed by Composite Interceptive Med Science for urinary and bladder support, currently in Phase 1 development. The product is formulated as a homeopathic tincture (1–10 drops sublingual, three times daily) and claims temporary relief of incontinence, bladder inflammation, and kidney support based on traditional use rather than FDA-reviewed clinical evidence. The clinical pipeline includes Phase 2 trials evaluating tulsi extract for oral mucositis in head and neck cancer patients and biochemical parameters in obesity management, suggesting potential expansion beyond urinary indications. As a botanical extract with no disclosed molecular target or mechanism of action, the product operates in the unregulated homeopathic space with limited commercial data and no patent protection disclosed. The company has not disclosed revenue figures, market size, or competitive positioning; regulatory pathway and commercial viability remain unclear given the homeopathic classification and lack of conventional clinical development.

At a glance

Generic nameOcimum Sanctum
SponsorComposite Interceptive Med Science
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.